The U.S. federal government is about to spend nearly a billion dollars buying a whole lot of new COVID-19 test kits.
But the kits, antigen tests from Abbott Laboratories, aren’t perfect—and neither is their manufacturer’s track record. There’s also the prospect that this kind of test, which at least one state health department has previously used to isolate “probable” cases from “confirmed” ones, could be used to dilute the number of COVID-19 cases reported across America.
Welcome to Rabbit Hole, where we dive deep on the biggest story. It’s for Beast Inside members only. Join up today.